Gerd Auffarth
CIK 1649867 · last filed 2025-10-03
Gerd Auffarth is a corporate insider who has filed 19 SEC Form 4 insider transactions across 3 companies since 2015. The most recent filing, for OTLK, was dated Oct 3, 2025. Current disclosed insider exposure totals $1.6M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$1.61M
3
19
$0
Holdings By Company
Recent Filings
19 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-10-03 | OTLK | Grant (A) | — | $0 | EDGAR |
| 2024-10-03 | OTLK | Grant (A) | — | $0 | EDGAR |
| 2024-03-08 | OTLK | Grant (A) | — | $0 | EDGAR |
| 2023-10-05 | OTLK | Grant (A) | — | $0 | EDGAR |
| 2023-03-31 | OTLK | Grant (A) | — | $0 | EDGAR |
| 2022-10-07 | OTLK | Grant (A) | — | $0 | EDGAR |
| 2022-03-24 | OTLK | Grant (A) | — | $0 | EDGAR |
| 2021-10-07 | Outlook Therapeutics, Inc. (OTLKW) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-03-26 | Outlook Therapeutics, Inc. (OTLKW) Delisted | Grant (A) | — | $0 | EDGAR |
| 2020-10-05 | Outlook Therapeutics, Inc. (OTLKW) Delisted | Grant (A) | — | $0 | EDGAR |